Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 4
2017 3
2018 1
2019 4
2020 3
2021 3
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer.
Mathiot L, Nigen B, Goronflot T, Hiret S, Doucet L, Pons-Tostivint E, Bennouna J, Denis MG, Herbreteau G, Raimbourg J. Mathiot L, et al. Among authors: herbreteau g. Clin Lung Cancer. 2023 Dec 13:S1525-7304(23)00260-7. doi: 10.1016/j.cllc.2023.12.004. Online ahead of print. Clin Lung Cancer. 2023. PMID: 38218680 Free article.
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib.
Morin G, Degrugillier-Chopinet C, Vincent M, Fraissenon A, Aubert H, Chapelle C, Hoguin C, Dubos F, Catteau B, Petit F, Mezel A, Domanski O, Herbreteau G, Alesandrini M, Boddaert N, Boutry N, Broissand C, Han TK, Branle F, Sarnacki S, Blanc T, Guibaud L, Canaud G. Morin G, et al. Among authors: herbreteau g. J Exp Med. 2022 Mar 7;219(3):e20212148. doi: 10.1084/jem.20212148. Epub 2022 Jan 26. J Exp Med. 2022. PMID: 35080595 Free PMC article.
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.
Herbreteau G, Langlais A, Greillier L, Audigier-Valette C, Uwer L, Hureaux J, Moro-Sibilot D, Guisier F, Carmier D, Madelaine J, Otto J, Souquet PJ, Gounant V, Merle P, Molinier O, Renault A, Rabeau A, Morin F, Denis MG, Pujol JL. Herbreteau G, et al. J Clin Med. 2020 Nov 27;9(12):3861. doi: 10.3390/jcm9123861. J Clin Med. 2020. PMID: 33261056 Free PMC article.
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutation.
Le Calvez B, Le Bris Y, Herbreteau G, Jamet B, Bossard C, Tessoulin B, Gastinne T, Mahé B, Dubruille V, Blin N, Antier C, Theisen O, Kraeber-Bodéré F, Le Gouill S, Béné MC, Moreau P, Touzeau C. Le Calvez B, et al. Among authors: herbreteau g. EJHaem. 2020 Aug 6;1(1):318-322. doi: 10.1002/jha2.8. eCollection 2020 Jul. EJHaem. 2020. PMID: 35847743 Free PMC article.
23 results